Breast Cancer Now/Prostate Cancer Research Bone Metastasis Collaboration Fund
Closing Date: 28/10/2024
Funding is available for research investments into discovery science in the field of prostate cancer in the UK.
Prostate Cancer Research (PCR) is a charitable organisation dedicated to funding research that will deliver a world where people are free from the impact of prostate cancer. PCR is delivering this opportunity in partnership with Breast Cancer Now (BCN), a charitable organisation dedicated to researching a cure for breast cancer.
The Bone Metastasis Collaboration Fund aims to bring together experts and take a collaborative and multi-tumour approach to research in order to revolutionise the prevention, diagnosis, treatment, and care of bone metastasis in breast and prostate cancer. The grant invites proposals from UK-based principal investigators addressing the following criteria, or a combination:
- Research investigating the fundamental mechanisms of bone metastasis that are cancer-agnostic.
- Research focused on the prevention, diagnosis, treatment, and care of bone metastasis. This may relate to breast cancer, prostate cancer, or both. Research that addresses issues relevant to both cancers will be of particular interest.
- Research focused on breast cancer or prostate cancer.
- Projects looking to combine approaches in models of both breast and prostate cancers.
- New collaborations of teams working on breast and prostate cancer.
Proposals must align with PCR’s Strategy and BCN’s strategy. Proposals that involve community groups and patients as co-investigators or collaborators are encouraged.
Funding body | Prostate Cancer Research (PCR) |
---|---|
Maximum value | £250,000 |
Reference ID | S26868 |
Category |
Medical Research Biotechnology and Biology |
Fund or call | Fund |